clinical cancer research under review 发表经验clinical cancer research under review发表经验 clinical cancer research under review发表经验:癌症临床研究综述发表经验©2022 Baidu |由 百度智能云 提供计算服务 | 使用百度前必读 | 文库协议 | 网站地图 | 百度营销 ...
人生第一篇10分+SCI当然要分享Accept经验啦 Accept杂志《Clinical Cancer Research》 第一次中10分以上杂志是CCR!第一次大修修回秒接是CCR给的! 正式接受是在24年第一篇!! 投稿时间线我是背 - 毕业论文辅导于20240517发布在抖音,已经收获了2050个喜欢,来抖音,记录美好
请问投过clinical cancer research的大佬们,一般under review需要出现多久才可能是送审了呢?如有中的大佬求贴一下时间线~
Research May 23, 2024 Select Your Interests Others Also Liked We recommend Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan Chin-Hsiao Tseng, European Journal of Endocrinology-1, 2012 Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch ...
Singapore has been investing in nurturing clinician scientists to build up human capital for clinical research. In 2008, the Translational and Clinical Research (TCR) Flagship Program was launched, focusing on the five key disease areas of cancer, metabolic disorders, infectious diseases, neurosciences...
Journal of Experimental & Clinical Cancer Research BioMed Central Research Open Access Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model Daher C Chade1, Ricardo C Borra2, Ivan P Nascimento3, Fabiola E Villanova4, Luciana CC ...
引用Journal of Cancer Research and Clinical Oncology次数排名前20的期刊 网友评价 经验分享1:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。 经验分享2:2023-05-15,肿瘤方向meta,第二天秒拒。 经验分享3:肿瘤学;乳腺癌;临床,反馈来啦～效率巨高 4.19 submission received 4.19 under review 5.4 让推荐...
Close Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly. Email address Sign up I agree my information will be processed in accordance with the Nature and Springer Nature Limited Privacy Policy....
《JournalofCancerResearchandClinicalOncology》是中科院医学大类三区期刊,在过去三年里,国内学者的发文量位居第一。从期刊官网整理了一些与该期刊相关的信息,现在与大家共享。投稿经验分享分享一:研究方向:肿瘤学投稿结果:修改后录用投稿时间节点:publishingandrig
Potential combinations of cytokine-based drugs with other modalities of cancer immunotherapy. Cytokines have been dichotomised into immunostimulatory cytokines (blue) and immunosuppressive cytokines (beige). The arrows indicate combinations with other immunotherapy approaches that are currently under research....